ArticleAnnals of medicine and surgery (2012)2026

A new horizon for Sjögren's disease: the FDA breakthrough designation of ianalumab.

Muhammad Qasim Safi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.